MedTrace Logo

Topical Chamomile in Preventing Chemotherapy-induced Oral Mucositis

NCT04317183 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2020-03-23

No results posted yet for this study

Summary

the main aim of this study is to clinically assess the effectiveness of topical chamomile oral gel in the prevention of chemotherapy-induced oral mucositis.

Conditions

  • Oral Mucositis Due to Chemotherapy

Interventions

DRUG

chamomile topical oral gel

Chemical constituents of chamomile, such as bisabolol, chamazulene, and the flavonoids apigenin and luteolin, possess anti-inflammatory properties.

DRUG

Miconazole Topical Gel

topical anti fungal agent

DRUG

BBC oral spray

Topical anesthetics and anti-inflammatory agent

DRUG

Oracure gel

Topical analgesic gel

Sponsors & Collaborators

  • Hams Hamed Abdelrahman

    lead OTHER

Principal Investigators

  • Ehsan El-Negomy, PhD · Alexandria University

  • Maha Talaab, PhD · Alexandria University

  • Reham Ibrahim, Phd · Alexandria University

  • Rasha El-Saka · Alexandria University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-15
Primary Completion
2020-03-15
Completion
2020-03-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04317183 on ClinicalTrials.gov